ARE LABS / RESEARCH
Explore the questions we investigated, the measurements we made and what the results mean for product development.
3 studies found
Inhalation & Drug Delivery
The study established an early performance baseline for comparing the two variants and provided data for a regulatory-facing Phase 1 characterization package. It did not assess clinical efficacy or support claims of approval.
Selected findingRecovered material was predominantly classified in the nasal or upper-airway region for both variants.
Aerosol Characterization
The study characterized differences among the tested fragrance aerosols in spray particle-size distribution and time-resolved chamber counts under defined conditions.
Selected findingGroup-average D[4,3] was 31.49 µm for Test Article A and 75.03-89.77 µm for Comparator groups B-D.
Exposure Assessment
The work helped the client answer the relevant inhalation exposure question instead of relying on a broad bulk-material screen.
Selected findingThe method focused on the respirable aerosol fraction of the powder rather than total TiO2 in the compact.